Compare Heron Therapeutics Inc (HRTX) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Tilray Brands Inc — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Tilray Brands Inc trades at $4.24 (market cap $524.07M). The key difference: Tilray Brands Inc is far larger — about 5.7× Heron Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| HRTX | TLRY | |
|---|---|---|
Market Cap | $91.46M | $524.07M |
Sector | Health | Health |
52-Week High | $1.96 | $21.00 |
52-Week Low | $0.39 | $4.23 |
Enterprise Value | $189.36M | $621.22M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
